These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3011760)

  • 1. Central dopaminergic and noradrenergic receptor blockade in a patient with neuroleptic malignant syndrome.
    Ansseau M; Reynolds CF; Kupfer DJ; Poncelet PF; Franck G; Dresse AE; Reznik M
    J Clin Psychiatry; 1986 Jun; 47(6):320-1. PubMed ID: 3011760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome and dopaminergic blockade.
    Hashimoto F; Sherman CB; Jeffery WH
    Arch Intern Med; 1984 Mar; 144(3):629-30. PubMed ID: 6703834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoamine imbalance of the central nervous system in a case of Shy-Drager syndrome with recurrent attacks of a neuroleptic malignant syndrome].
    Ueda M; Hamamoto M; Otsubo K; Miyazaki T; Terashi A
    Rinsho Shinkeigaku; 1996 May; 36(5):696-8. PubMed ID: 8905993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome: a review of the literature.
    Pearlman CA
    J Clin Psychopharmacol; 1986 Oct; 6(5):257-73. PubMed ID: 2877012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors.
    Hermesh H; Huberman M; Radvan H; Kott E
    J Nerv Ment Dis; 1984 Nov; 172(11):692-5. PubMed ID: 6238132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Torecan-induced neuroleptic malignant syndrome].
    Bulvik S; Shimoni Z; Kaplan CL
    Harefuah; 1990 May; 118(10):576-8. PubMed ID: 2358219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases].
    Kimura T; Yoshida H
    No To Shinkei; 1994 Sep; 46(9):859-62. PubMed ID: 7999444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroleptic malignant syndrome, syndrome malin].
    Takahashi A; Todoroki J; Murasaki M
    Nihon Rinsho; 1996 Mar; 54(3):839-44. PubMed ID: 8904246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine in the treatment of neuroleptic malignant syndrome.
    Thomas P; Maron M; Rascle C; Cottencin O; Vaiva G; Goudemand M
    Biol Psychiatry; 1998 Feb; 43(4):303-5. PubMed ID: 9513741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome: need for early diagnosis and therapy.
    Khan HM; Syed NA; Sheerani M; Khcalani B; Kamal A; Wasay M
    J Ayub Med Coll Abbottabad; 2006; 18(1):17-21. PubMed ID: 16773963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
    Rock W; Elias M; Lev A; Saliba WR
    Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol.
    Bellamy CJ; Kane-Gill SL; Falcione BA; Seybert AL
    J Trauma; 2009 Mar; 66(3):954-8. PubMed ID: 19276778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome following autologous peripheral blood stem cell transplantation.
    Garrido SM; Chauncey TR
    Bone Marrow Transplant; 1998 Feb; 21(4):427-8. PubMed ID: 9509981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome.
    Signer SF
    J Clin Psychiatry; 1986 Sep; 47(9):483. PubMed ID: 3745135
    [No Abstract]   [Full Text] [Related]  

  • 19. [A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].
    Kawajiri M; Ohyagi Y; Furuya H; Araki T; Inoue N; Esaki S; Yamada T; Kira J
    Rinsho Shinkeigaku; 2002 Feb; 42(2):136-9. PubMed ID: 12424963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemostatic evaluation of a patient with haloperidol-induced neuroleptic malignant syndrome associated with disseminated intravascular coagulation].
    Seki Y; Takahashi H; Aizawa Y
    Rinsho Ketsueki; 1998 May; 39(5):374-8. PubMed ID: 9637888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.